Institute for Personalized and Translational Medicine
@translation-med.com
Despite unprecedented scientific breakthroughs made in recent years, a dramatically wide gap remains between understanding biological processes in the human body and practical tools used in conventional medicine. Translational medicine may be compared to “Esperanto”, as it is accepted by both medical and research communities for combining efforts and facilitating advanced scientific, sophisticated and productive solutions for real life applications. IPTM, established in 2014 by Dr. Igor Koman at Ariel University, aims to enrich translational technologies by evoking the philosophy of personalization to find exclusive solutions for individual patients’ unmet clinical needs. Our team, which includes experts in biological sciences and medicine, views the patient as a complete holistic system, in which all individual parameters are linked to one another, each having equal value and the potential to influence the final outcome. By adhering to a patient-centered approach, we develop two parallel, but tightly interrelated arms of our research activities: identification of unique individual therapeutic targets and an intensive search for safe and highly effective agents acting towards these targets.
Institute for Personalized and Translational Medicine's Company Logos
Institute for Personalized and Translational Medicine's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#AFD33E
Conifer
175, 211, 62
74, 63, 54
17, 0, 71, 17
#E1A577
Tumbleweed
225, 165, 119
26, 64, 67
0, 27, 47, 12
#142448
Bunting
20, 36, 72
222, 57, 18
72, 50, 0, 72
About Institute for Personalized and Translational Medicine
Institute for Personalized and Translational Medicine is at the forefront of creating innovative and personalized solutions for cancer, utilizing academic research and a focus on practical applications in the clinic. Founded in 2014 by Dr. Igor Koman at Ariel University, IPTM aims to bridge the gap between biological understanding and medical practice through translational medicine.
Our expert team, comprising professionals in biological sciences and medicine, takes a holistic view of patients, recognizing the interconnectedness of individual parameters in influencing treatment outcomes. By adopting a patient-centered approach, we identify unique therapeutic targets and research safe, highly effective agents to act on these targets. Our research spans areas such as transnational oncology, tumor development, data analysis, drug development, and cannabinoid research.
Contact us to learn more about how IPTM is revolutionizing cancer treatment with personalized and effective solutions
Brand industry
Science and Education
Company type
Partnership
Year founded
2014
Company size
11-50 employees
